62010-39-3 Usage
Uses
Used in Pharmaceutical Industry:
GQ1 ganglioside is used as a therapeutic agent for the treatment of neurological disorders, given its involvement in regulating cell growth, differentiation, and immune responses. It is particularly relevant in conditions such as Guillain-Barre syndrome, Miller Fisher syndrome, and Bickerstaff brainstem encephalitis, where autoantibodies target this specific ganglioside, leading to nerve damage and inflammation.
Used in Neurodegenerative Disease Research:
GQ1 ganglioside is used as a potential therapeutic agent in the research and treatment of certain neurodegenerative diseases. Its role in cell signaling and communication suggests that it may have applications in mitigating the progression of these conditions.
Used in Autoimmune Disorder Management:
GQ1 ganglioside is used as a potential treatment for autoimmune disorders, where its regulatory effects on cell growth, differentiation, and immune responses could be harnessed to manage the symptoms and progression of these diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 62010-39-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,2,0,1 and 0 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 62010-39:
(7*6)+(6*2)+(5*0)+(4*1)+(3*0)+(2*3)+(1*9)=73
73 % 10 = 3
So 62010-39-3 is a valid CAS Registry Number.